Injectable testosterone PLGA microsphere with different characteristics: effect of preparation method (paddle mixing versus microfluidic device)

References

• Blasi P, Schoubben A, Giovagnoli S, Perioli L, Ricci M, Rossi C. 2007. Ketoprofen poly(lactide-co-glycolide) physical interaction. AAPS PharmSciTech. 8(2):Article 37–E85. doi: 10.1208/pt0802037.
   PubMed Web of Science ®Google Scholar
• Boisdron-Celle M, Menei P, Benoit JP. 1995. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers. J Pharm Pharmacol. 47(2):108–114. doi: 10.1111/j.2042-7158.1995.tb05760.x.
   PubMed Web of Science ®Google Scholar
• Cheng CY, Pho QH, Wu XY, Chin TY, Chen CM, Fang PH, Lin YC, Hsieh MF. 2018. PLGA microspheres loaded with beta-cyclodextrin complexes of epigallocatechin-3-gallate for the anti-inflammatory properties in activated microglial cells. Polymers. 10(5):519. doi: 10.3390/polym10050519.
   PubMed Web of Science ®Google Scholar
• Czub MP, Venkataramany BS, Majorek KA, Handing KB, Porebski PJ, Beeram SR, Suh K, Woolfork AG, Hage DS, Shabalin IG, et al. 2019. Testosterone meets albumin - the molecular mechanism of sex hormone transport by serum albumins. Chem Sci. 10(6):1607–1618. doi: 10.1039/c8sc04397c.
   PubMed Web of Science ®Google Scholar
• Dedroog S, Adriaensens P, Van den Mooter G. 2022. Gaining insight into the role of the solvent during spray drying of amorphous solid dispersions by studying evaporation kinetics. Mol Pharm. 19(5):1604–1618. doi: 10.1021/acs.molpharmaceut.2c00095.
   PubMedGoogle Scholar
• DeYoung MB, MacConell L, Sarin V, Trautmann M, Herbert P. 2011. Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. Diabetes Technol Ther. 13(11):1145–1154. doi: 10.1089/dia.2011.0050.
   PubMed Web of Science ®Google Scholar
• Dunne M, Corrigan I, Ramtoola Z. 2000. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials. 21(16):1659–1668. doi: 10.1016/s0142-9612(00)00040-5.
   PubMed Web of Science ®Google Scholar
• FDA. 1997. FDA guidance for industry - dissolution testing of immediate release solid oral dosage forms. [accessed 2024 Apr 12]. https://www.fda.gov/media/70936/download.
   Google Scholar
• Fini A, Ospitali F, Zoppetti G, Puppini N. 2008. ATR/Raman and fractal characterization of HPBCD/progesterone complex solid particles. Pharm Res. 25(9):2030–2040. doi: 10.1007/s11095-008-9593-4.
   PubMed Web of Science ®Google Scholar
• Gilchrist SE, Rickard DL, Letchford K, Needham D, Burt HM. 2012. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres. Mol Pharm. 9(5):1489–1501. doi: 10.1021/mp300099f.
   PubMed Web of Science ®Google Scholar
• Higuchi T. 1963. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52(12):1145–1149. doi: 10.1002/jps.2600521210.
   PubMed Web of Science ®Google Scholar
• Kang SW, Jeon O, Kim BS. 2005. Poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering. Tissue Eng. 11(3-4):438–447. doi: 10.1089/ten.2005.11.438.
   PubMedGoogle Scholar
• Katou H, Wandrey AJ, Gander B. 2008. Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication. Int J Pharm. 364(1):45–53. doi: 10.1016/j.ijpharm.2008.08.015.
   PubMed Web of Science ®Google Scholar
• Kim H-G, Kim K-M, Kim YH, Lee SH, Kim GM. 2013. Preparation of monodisperse ENX-loaded PLGA microspheres using a microfluidic flow-focusing device. J Biobased Mat Bioenergy. 7(1):108–114. doi: 10.1166/jbmb.2013.1263.
   Web of Science ®Google Scholar
• Kim JH, Ryu CH, Chon CH, Kim S, Lee S, Maharjan R, Kim NA, Jeong SH. 2021. Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models. Int J Pharm. 611:121340. doi: 10.1016/j.ijpharm.2021.121039.
   PubMedGoogle Scholar
• Kojima R, Yoshida T, Tasaki H, Umejima H, Maeda M, Higashi Y, Watanabe S, Oku N. 2015. Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model. Int J Pharm. 492(1-2):20–27. doi: 10.1016/j.ijpharm.2015.07.004.
   PubMedGoogle Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci. 72(10):1189–1191. doi: 10.1002/jps.2600721021.
   PubMed Web of Science ®Google Scholar
• Li M, Rouaud O, Poncelet D. 2008. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 363(1-2):26–39. doi: 10.1016/j.ijpharm.2008.07.018.
   PubMed Web of Science ®Google Scholar
• Li W-I, Anderson KW, Deluca PP. 1995. Kinetic and thermodynamic modeling of the formation of polymeric microspheres using solvent extraction/evaporation method. J Control Release. 37(3):187–198. doi: 10.1016/0168-3659(95)00077-1.
   Web of Science ®Google Scholar
• Li WI, Anderson KW, Mehta RC, DeLuca PP. 1995. Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method. J Control Release. 37(3):199–214. doi: 10.1016/0168-3659(95)00076-3.
   Web of Science ®Google Scholar
• Liggins RT, Burt HM. 2004. Paclitaxel loaded poly(L-lactic acid) (PLLA) microspheres. II. The effect of processing parameters on microsphere morphology and drug release kinetics. Int J Pharm. 281(1-2):103–106. doi: 10.1016/j.ijpharm.2004.05.027.
   PubMedGoogle Scholar
• Lim YW, Tan WS, Ho KL, Mariatulqabtiah AR, Abu Kasim NH, Abd Rahman N, Wong TW, Chee CF. 2022. Challenges and complications of poly(lactic-co-glycolic acid)-based long-acting drug product development. Pharmaceutics. 14(3):614. doi: 10.3390/pharmaceutics14030614.
   PubMed Web of Science ®Google Scholar
• Liu B, Dong Q, Wang M, Shi L, Wu Y, Yu X, Shi Y, Shan Y, Jiang C, Zhang X, et al. 2010. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(dl-lactic-co-glycolic acid) microspheres. Chem Pharm Bull. 58(11):1474–1479. doi: 10.1248/cpb.58.1474.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3(3):1377–1397. doi: 10.3390/polym3031377.
   PubMed Web of Science ®Google Scholar
• Oe Y, Ogino S, Kobayashi M, Kojima H, Terukina T, Kanazawa T, Kondo H. 2022. Testosterone sustained release microspheres for the treatment of fecal incontinence. J Pharm Sci. 111(8):2322–2329. doi: 10.1016/j.xphs.2022.03.008.
   PubMed Web of Science ®Google Scholar
• Okada H, Doken Y, Ogawa Y, Toguchi H. 1994. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers. Pharm Res. 11(8):1143–1147. doi: 10.1023/a:108936815654.
   PubMed Web of Science ®Google Scholar
• Park K, Otte A, Sharifi F, Garner J, Skidmore S, Park H, Jhon YK, Qin B, Wang Y. 2021. Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles. J Control Release. 329:1150–1161. doi: 10.1016/j.jconrel.2020.10.044.
   PubMed Web of Science ®Google Scholar
• Pathak S, Gupta B, Poudel BK, Tran TH, Regmi S, Pham TT, Thapa RK, Kim M-S, Yong CS, Kim JO, et al. 2016. Preparation of high-payload, prolonged-release biodegradable poly(lactic-co-glycolic acid)-based tacrolimus microspheres using the single-jet electrospray method. Chem Pharm Bull. 64(2):171–178. doi: 10.1248/cpb.c15-00799.
   PubMed Web of Science ®Google Scholar
• Ritger RL, Peppas NA. 1987. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 5(1):37–42. doi: 10.1016/0168-3659(87)90035-6.
   Google Scholar
• Rumble JR, Bruno TJ, Doa MJ. 2022. CRC handbook of chemistry and physics: a ready-reference book of chemical and physical data. Boca Raton (FL): CRC Press.
   Google Scholar
• Shen J, Choi S, Qu W, Wang Y, Burgess DJ. 2015. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres. J Control Release. 218:2–12. doi: 10.1016/j.jconrel.2015.09.051.
   PubMed Web of Science ®Google Scholar
• Sreenivasan KR. 2019. Turbulent mixing: a perspective. Proc Natl Acad Sci U S A. 116(37):18175–18183. doi: 10.1073/pnas.1800463115.
   PubMedGoogle Scholar
• Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y. 2009. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(d,l-lactide-co-glycolide) microsphere. Chem Pharm Bull. 57(11):1251–1256. doi: 10.1248/cpb.57.1251.
   PubMed Web of Science ®Google Scholar
• Tao Y, Dong H, Ma Y, Han L. 2021. Preparation of poly lactic-co-glycolic acid-based implant biomaterials and its adoption in restoration of periodontal missing teeth. Sci Adv Mater. 13(4):694–704. doi: 10.1166/sam.2021.3962.
   Web of Science ®Google Scholar
• Thorsen T, Roberts RW, Arnold FH, Quake SR. 2001. Dynamic pattern formation in a vesicle-generating microfluidic device. Phys Rev Lett. 86(18):4163–4166. doi: 10.1103/PhysRevLett.86.4163.
   PubMed Web of Science ®Google Scholar
• Yang C-H, Huang K-S, Grumezescu AM, Wang C-Y, Tzeng S-C, Chen S-Y, Lin Y-H, Lin Y-S. 2014. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison. Electrophoresis. 35(2-3):316–322. doi: 10.1002/elps.201300185.
   PubMed Web of Science ®Google Scholar